We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Resuscitation Unit Boosts Health of Newborn Babies

By HospiMedica International staff writers
Posted on 29 Jan 2013
An innovative resuscitation unit facilitates delayed cord clamping (DCC) for neonates, promoting many health benefits. More...


The Inditherm Lifestart resuscitation unit offers a compact design and the ability to deliver all the required functions close enough to the mother, thus permitting the umbilical cord to be left intact for the critical first few minutes. Most studies show that at least three minutes of DCC gives the most health benefits, in addition to the emotional and bonding advantage, as the baby does not need to be separated from its mother in the first minutes after delivery. The unit was designed with guidance from a multicenter team of obstetricians and pediatricians who have been conducting extensive research on DCC.

Among the health benefits of DCC are a significant increase in blood volume; continued supply of oxygenated blood; lower risk of requiring transfusion; reduction in anemia and iron deficiency; and a potential reduction in long-term cognitive and behavioral problems. The Inditherm Lifestart resuscitation unit is a product of Inditherm Medical (Rotherham, United Kingdom), and complements a range of ancillary products, such as the CosyCrib baby nest and hoods and covers which fit to cribs, cots, and incubators, to protect babies from light and draughts and reduce the impact of external noise.

“The evidence for DCC is very compelling and there is a growing clamor from the clinical community to change historic practice,” said Nick Bettles, CEO of Inditherm Medical. “We are delighted to be leading the market by providing the necessary equipment to enable widest uptake of such an important change, which will inevitably lead to healthier babies.”

The strength of the evidence favoring DCC, as indicated in many studies, has led to changes in the guidelines issued by many key bodies in obstetrics and gynecology, such as the World Health Organization (WHO; Geneva, Switzerland) and the Royal College of Obstetricians & Gynaecologists (London, united Kingdom).

Related Links:
Inditherm Medical
World Health Organization
Royal College of Obstetricians & Gynaecologists


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.